Kolexia
Attar Alain Gastro-entérologie
Attar Alain
Gastro-entérologie
Clinique Turin
Paris, France
59 Activités
32 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Sténose pathologique Maladies inflammatoires intestinales Malnutrition Occlusion intestinale Rectocolite hémorragique Hypertension artérielle Perte de poids Hémorragie

Collaborateurs

Voir plus
Dieumegard Barbara
Dieumegard Barbara
Clinique Turin, Paris, France
Iglicki Franck
Iglicki Franck
Hôpital Louis-Mourier, Colombes, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Bouhnik Yoram
Bouhnik Yoram
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France

Industries

Voir plus
Janssen
24 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
13 collaboration(s)
Dernière en 2023
Amgen
10 collaboration(s)
Dernière en 2023
Tillotts
7 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Inflammatory bowel diseases   05 avril 2023
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAID.
Inflammatory bowel diseases   02 août 2022
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID.
Journal of Crohn's & colitis   06 décembre 2021
An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED.
Journal of Crohn's & colitis   05 novembre 2021
Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study.
Journal of Crohn's & colitis   12 février 2020
P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
Abstracts of the 15th Congress of ECCO Vienna, Austria, February 12–15, 2020   15 janvier 2020
Cost savings using a test-based de-escalation strategy for patients with Crohn's disease in remission on optimized infliximab: A discrete event model study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   05 septembre 2018
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review.
Journal of gastroenterology   24 septembre 2016
Stent for Crohn's disease strictures: Which one and when?
Endoscopy international open   23 mars 2016
Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab.
Journal of market access & health policy   30 octobre 2015